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1. Introduction
The anthrax attacks that occurred in 2001 brought into sharp focus many issues
concerning the vulnerability of the United States to the threat of bioterrorism. 
Bioterrorism, instead of being an event that occurred in distant places, became a reality 
on American soil. These attacks were a true test of how the United States could respond 
and react to bioterrorism and demonstrated that America needed to establish more 
effective programs of preparedness and quick response. An effective program should
include everything from defense against a bioattack, to early detection and identification, 
isolation of affected victims, and availability of adequate supplies of vaccines and drugs 
for treatment.
One of the aspects of being prepared is the ability to quickly detect, identify, and 
determine the origin of a bioterrorism agent. In 2002, the government passed The Public 
Health Security and Bioterrorism Preparedness and Response Act of 2002. This 
legislation expanded, enhanced, and improved the capabilities of the Centers for Disease 
Control and Prevention (CDC) to respond to an attack. It also made available billions of 
dollars for enhanced training of responders, for production of vaccines, growth of 
facilities, and research (Public Health Security, 2002). State governments also tried to do 
their part in the fight on terrorism. Oklahoma, for example, hosted a seminar composed 
of key staff and representatives from federal and local agencies. The seminar, sponsored 
by the Oklahoma City National Memorial Institute for the Prevention of Terrorism,
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MIPT, was held to discuss how to prepare, educate, and respond to a local bioterrorism 
attack (Validating Oklahoma Bioterrorism Planning, 2002). There was a strong interest in 
developing rapid, presumptive identification capability for bioterrorist agents at a local 
level due to the loss of critical time when a state lab sends specimens of suspected 
infectious agents to the CDC for analysis (Validating Oklahoma Bioterrorism Planning, 
2002).   
Bioterrorism was first documented in the French and Indian War when the British gave
Native Americans blankets that had previously been used by smallpox victims. There 
have been reported instances of the intentional use of infectious agents in every major 
war since (Bioterrorism [CD Rom]). In addition, although there has been no recent 
intentional use of biological weapons, Germany, Japan, the United Kingdom, Iraq, the 
former Soviet Union, and the United States are all suspected of having experimented with 
anthrax (Timeline, 2001). In fact, Iraq admitted in 1995, to having 8,500L of 
concentrated anthrax and 19,000L of concentrated Botulism toxin on hand, which is 
enough to kill the entire human population almost three times over (Arnon et. al., 2001, 
Timeline, 2001). Based on past history, recent events, and the future threat of agents such 
as anthrax being used as biological weapons, research is needed to enhance the detection 
and identification of bacterial strains and viruses that pose a biowarfare threat. 
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Category A B C
Definition High priority agents that 
pose a risk to national 
security
Moderate priority agents Lowest priority agents 
and emerging pathogens
Examples Anthrax, Botulism, 
Smallpox, Plague
Brucellosis, Salmonella, 
Q Fever, Typhus Fever
Nipah Virus, Hantavirus
Table 1. CDC’s categories of Bioterrorism Agents/Diseases. The CDC list the agents according to priority 
which is determined by mortality rates, ease of production, and possible social disruption and public panic
(Bioterrorism Agents/Diseases, 2004).  
Table 1 was created by the CDC and provides a list of possible bioterrorism weapons. 
One of the most notable bioweapons is anthrax. Anthrax has existed throughout recorded 
history. It is believed that the fifth plague described in Genesis was anthrax and it is also 
described in the early literature of the Greeks and Romans (Morse, 2002). One of the best 
documented natural outbreaks occurred in 1979/1980 in Zimbabwe, infecting animals 
and over 6,000 humans, killing almost 100 humans (Timeline, 2001). These outbreaks are 
relatively rare in the United States with only 236 cases of anthrax infecting human 
patients reported between 1955 and 1999 (Anthrax:NIAID Fact Sheet, 2002). Anthrax
outbreaks occur because Bacillus anthracis (B. anthracis), the causative organism, is a 
normal inhabitant of soil and water. When the bacterium is in its spore stage, it has the 
capability of infecting organisms and elaborating its toxic properties. Grazing animals eat 
contaminated vegetation or soil and become infected. If a human comes into contact with 
the animals flesh, bones, hides, hair, or excrement, they too can become infected (Ryan, 
1994).
Interestingly, Bacillus anthracis was the first bacterium to be identified as the causative 
agent of a disease. In 1876, Robert Koch injected livestock with B. anthracis and 
demonstrated that they then became ill. (Ryan, 1994). It wasn’t until 1954, however, that 
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the toxic properties associated with B. anthracis infection were characterized (Todar, 
2004). Included in these toxic factors are a protective antigen, an edema factor, and a 
lethal factor. The protective antigen is responsible for binding to cells of the infected life 
form and producing a channel through which the edema and lethal factors can enter. The 
edema factor, which has been identified as adenylate cyclase, causes fluid to accumulate 
in the lungs (Leppla, 1982). The lethal factor is a zinc-metalloprotease , which disrupts 
normal hemoestatic function (Klimpel et. al., 1994, Hanna, 1999). In addition to toxic 
factors that cause harm to an infected cell, B. anthracis is protected by a cell wall 
capsule, consisting of a high content of poly-D-glutamic acid, which helps protect
vegetative cells from elimination from the body of the infected host. (Ryan, 1994).   
There are three different types of human infections caused by B. anthracis. In rare 
occurrences, a person can eat infected, undercooked meat or drink contaminated water 
and obtain one form of anthrax known as gastrointestinal anthrax. The symptoms include 
nausea, fever, abdominal pain, and vomiting of blood (Morse, 2002).  The most common 
and the most treatable form of anthrax is the cutaneous form which occurs when spores 
enter the skin through a cut or opening (Figure 1). Cutaneous anthrax begins as an itchy 
bump that becomes fluid-filled and ruptures into a painless ulcer (Morse, 2002).  
Figure 1. Cutaneous anthrax infection. Example of a human four day old  anthrax infection 
(http://www.bt.cdc.gov/agent/anthrax/anthrax-images/cutaneous.asp).
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The most deadly form of anthrax, and the infection that would be the goal of a 
bioterrorist attack, is inhalation anthrax. This form results when spores are inhaled into 
the lungs (Inglesby, 2002). Inhalation anthrax is deadly because the toxic factors 
described above destroy white blood cells, the body’s first line of defense against the 
pathogen. The toxins also disable signaling of other elements of the immune system. The 
overall breakdown of the immune system allows the bacteria to remain undetected in the 
lungs and to survive and reproduce. When the first respiratory symptoms of inhalation 
anthrax appear, it is usually too late for treatment that will ensure the survival of the 
patient. This is why death seems to occur so quickly and unexpectedly after diagnosis. 
Death is apparently due to oxygen depletion, secondary shock, and respiratory and 
cardiac failure (Todar, 2004).
B. anthracis is a large, aerobic, gram-positive, rod-shaped, non-motile, spore-forming 
bacterium (Koneman et. al., 1998). The genome of B. anthracis is over 5.2 million base 
pairs long and exists as a single chromosome. B. anthracis also harbors extra-
chromosomal, circular plasmids that generally carry the genes for all the toxic properties 
(Read et. al., 2003). At the genomic level B. anthracis is believed to be one of the most
homogenous species known (Keim et. al., 2000). The small variation that is found among 
different strains could explain differences in antibiotic sensitivity (Read et. al., 2003). 
These subtle differences in DNA sequences are also of great importance to public health 
investigators hoping to pinpoint the origin of an outbreak.    
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The CDC classifies anthrax as a Category A agent. This means that it is considered the 
highest threat to national security due to its ease of transmission, potential for causing 
public panic, and high rate of death and illness, especially in the case of inhalation 
anthrax (Anthrax:NIAID Fact Sheet, 2002). Anthrax is a good biological weapon for 
terrorism for many reasons. First, it is relatively easy and inexpensive to produce in large 
quantities since the knowledge concerning how to culture the microbe is readily 
available. Once produced, anthrax spores have a long shelf life. Spores are persistent in 
the environment and could conceivably contaminate the environment for months or even 
years (University of Alabama at Birmingham, 2004). Other features of anthrax that make 
it attractive as a bio-weapon include the limited capabilities for detection and high rate of 
infection. One gram of anthrax spores is equivalent to 100 million infectious doses, 
making it 100,000 times more deadly than the deadliest chemical warfare agent (United 
States Department of Defense, 1998). The US Army views anthrax as a potential threat 
due to the fact that the spores are resistant to destruction, it can easily be spread through 
the air, and there is documented development and existing stockpiles of the bacterium in 
foreign countries (Anthrax, 2002). 
Bacillus cereus (B. cereus) is a close relative of B. anthracis and is genetically very 
similar. Since this lab is not certified as a Biological Safety Level-2 lab and could not 
perform research on the dangerous organism, B. cereus was used as a model organism for 
B. anthracis. Bacteria belonging to the Bacillus genus are all spore-forming and, besides 
Clostridium, represent the only bacteria that have sporulation capability. Bacillus species 
are also ubiquitous, found mostly in soil, but also found in water, dust, and even as 
7
natural flora in the human intestine (Koneman et. al., 1988). Similarities in phenotypes 
between B. cereus and B. anthracis include a rod shape, inhabitating the soil, and being 
gram positive. However, B. cereus is motile while B. anthracis is not (Bacillus cereus
and other Bacillus spp., 2002). 
Figure 2. Hemolysis represented on blood agar. B. cereus colonies shown on left and B. anthracis colonies
shown on right, providing a visual differentiation between the two strains of Bacillus (Todar, 2004).
B. cereus can be toxic causing a non-fatal, food-borne intoxication. B. cereus exhibits 
two different types of poisoning, an emetic form (causing vomiting) and a diarrheal form
(Moravek et. al., 2004). The toxin that causes diarrhea is thought to be a non-hemolytic 
entertoxin, or NHE, isolated from food poisoning outbreaks. The nheAB genes encode 
NHE and are homologous to some genes found in B. anthracis (Mendelson, et. al, 2004). 
Another study suggested the existence of an additional toxin, called hemolysis BL-
enterotoxin, or HBL, that complements NHE in causing food poisoning from the 
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ingestion of B. cereus (Moravek et. al., 2004). B. cereus, which is an opportunistic 
pathogen, can also cause diseases of the eye following trauma. B. cereus contaminated 
dust or soil that enters the eye following an injury can be very destructive and can lead to 
loss of vision (Howard, 1987).
Many studies have been conducted testing the relatedness exhibited among Bacillus 
species. One such study found that Bacillus species are genetically similar and B. cereus
even contains a plasmid that is similar to one of the two that B. anthracis possesses
(Rasko et. al., 2004). Read et. al. (2003) compared genomic hybridization tests of B. 
cereus and B. thuringiensis against B. anthracis and confirmed many genomic 
similarities between the species. In fact, when nineteen members of the B. cereus group 
were compared to B. anthracis they were found to share 66-92% of their chromosomal 
genes. In a study by Radnedge et. al. (2003), only 93 nucleotide sequences were 
identified in the genome of B. anthracis that were not found in the genome of other 
Bacillus species. 
Traditional approaches for the comparison of Bacillus species have included colony 
morphology, biochemical pathway testing, and the use of Gram staining. These tests are 
time consuming, labor intensive, and interpretation of results can be subjective. At the 
DNA level, one group of researchers found that the Polymerase Chain Reaction, or PCR,
could be used to distinguish among species, and even found different DNA fingerprints 
within each strain, suggesting subtypes exist and can be distinguished using PCR (Webb
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et. al., 2003). Molecular assays such as PCR can exhibit a higher degree of specificity, 
are rapid to perform, and less labor intensive than classic methods for identification.
DNA typing, also known as DNA fingerprinting, was first described in 1985, by Sir Alec 
Jefferys. Jefferys found regions in human DNA associated with the myoglobin genes that 
contain sequences that are repeated consecutively over and over again (Jeffreys et. al., 
1985). Moreover, Jeffreys found that the number of repeats differs among individuals. 
The regions of genomic DNA that are repeated became known as variable number of 
tandem repeats, or VNTRs (Nakamura et. al., 1987) . Jeffreys used the restriction
fragment length polymorphism procedure (RFLP) to create a fingerprint of a DNA 
sample. This procedure uses restriction enzymes that target the areas surrounding the 
repeated sequences (Botstein et. al., 1980). Producing a complete DNA fingerprint 
usually takes about 4-6 weeks, is labor intensive, and, to process the sample, at least 
100ng of intact DNA is needed (Butler, 2001).  In the mid-1980s, Saiki et. al. (1985) used 
a process that was described by Kary Mullis and discovered it was possible to amplify
VNTR loci using PCR. For reasons of speed, sample type and amount, and ease of use, 
PCR amplification of VNTR loci replaced RFLP mapping as the principle DNA typing 
methodology (Butler, 2001). 
PCR is an enzymatic process used to copy short, known sequences of target DNA. The 
process is similarly modeled on natural DNA replication within a cell. PCR uses 
alternating cycles of heat denaturation and cooling during which thermostable DNA 
polymerase replicates a nucleotide sequence of interest. This sequence is specified by 
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oligonucleotide primers that are added to the reaction and are complementary to the 5’ 
and 3’ ends of the target DNA (Hartl and Jones, 2005). By performing 20-35 cycles of 
heating and cooling, millions of copies of a given DNA sequence can be produced
(Figure 3). The advantage of PCR over RFLP is that it is relatively simple and reasonably 
fast, allowing for a quick turn-around of results (Budowle et. al., 2002). More 
importantly, an extremely small amount of DNA template (50-100pg) can be amplified 
even if it is partially degraded because the procedure is sensitive. The principal 
disadvantage of PCR also relates to sensitivity, meaning contamination becomes a greater 
threat to the validity of results (Budowle et. al., 2002). 
Figure 3. Representation of a typical PCR amplification with known primers (Butler, 2001).
In designing a typical PCR reaction, the sequence of the target area of DNA must be 
known. Knowing the nucleotide sequence of the target DNA allows primers to be 
synthesized that are complementary to the boundaries of the target sequence. The two 
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primers added to a PCR reaction bind to the 3’end of each strand of DNA and serve as
the initiation points for replication catalyzed by DNA polymerase (Hartl and Jones, 
2005).     
Random Amplification of Polymorphic DNA, or RAPD, is a variation of traditional PCR 
and is designed to be used with DNA templates whose sequences are not known or well 
characterized. Williams et. al. (1990), used single olignucleotide primers with arbitrary 
nucleotide sequences to amplify polymorphic DNA segments that are inherited in a 
Mendelian fashion and was able to construct genetic maps among members of plant and 
animal species. Because the primers used exhibited a high degree of sequence variability, 
polymorphic regions of the genome can be amplified in the absence of specific 
knowledge of nucleotide sequence (Williams et. al., 1990). In order for a RAPD product 
to be produced, the primers must hybridize to a target sequence in the genome and be 
spaced on opposite DNA strands in close enough proximity to form primer pairs that can 
efficiency amplify a PCR product.  In figure 4, primers labeled as 2 and 5 are able to 
produce a product, product A, and primers 3 and 6 also have opposite orientations and are 
in close enough proximity to produce product B. Primers 1 and 4 are also in opposite 
directions, but are not close enough to direct the efficient amplification of a PCR product.
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Figure 4. RAPD analysis producing two products. This example shows a simple example of RAPD 
primers binding to a DNA template in an orientation where two different size products were produced.
Variation in the products produced with all PCR procedures occurs due to nucleotide 
sequences differences occurring in the DNA template. When using RAPD analysis this 
variation can make primers bind in different places, different orientations, or they might
not bind to the templates at all. In figure 5, the DNA template is different from the figure 
shown above, because the primer labeled number 2 does not bind to DNA Template #2 
and product A is not produced. 
1 2
4 5 6
3
Product 
    B
DNA 
Template
#1
PCR 
Reaction
Product 
     A
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Figure 5. RAPD analysis producing one product. This picture shows a simple example of how a different 
DNA template has different binding patters and therefore, different products produced. 
If amplification products from the templates shown in figures 5 and 6 were analyzed 
using gel electrophoresis, which separates DNA molecules based on size, results shown 
in figure 6 would be obtained. 
1
4 5 6
3
Product 
    B
DNA 
Template
#2
PCR
Reaction
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Figure 6. Results of the simple RAPD example. Agarose gel results of the two DNA templates. Lane one 
contains a size ladder, while lane 2 portrays the products produced in Figure 5 and lane 3 portraits the 
products produced from Figure 6.
Since these early studies other researchers have applied the RAPD procedure in different 
ways. One group performed parentage testing on burying beetles (Nicrophorus 
tomentosus: Silphidae) and was able to establish a relationship between parents and 
offspring. An exception was that they found occasional non-parental products that were 
detected at low frequencies in offspring (Scott et. al., 1992). Similar results were found 
by another group studying a flax rust fungus. Detailed analysis revealed that the spurious 
amplification products represented heteroduplex molecules that formed between two 
allelic sequences of different sizes, explaining the non-parental products visualized in the 
Scott et. al.(1992) study (Ayliffe et. al., 1994).
Harrison et. al. (1992), used RAPD in conjunction with DNA from Rhizobium 
leguminosarum to differentiate strains in order to examine genetic structure and 
relationships within the population. Other groups studied many other organisms with 
1 2
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many different random primers and all have found RAPD to be efficient, flexible, rapid, 
and useful as a tool for identifying and typing organisms (Soto et. al., 1999). All have 
demonstrated RAPD to reveal polymorphism in genomic DNA and therefore it is capable 
of producing a DNA fingerprint (Melcher, 2001). RAPD can be a powerful tool for gene 
mapping, population genetics, pedigree analysis, phylogenetic studies, surveying DNA 
for damage or mutation, and strain identification (Atienzar et. al., 2001). In most studies, 
10bp oligonucleotide primers with at least a 50% GC content seem to represent optimal 
primers for RAPD analysis (Williams et. al., 1990).
An example of the forensic use of RAPD occurred when an investigator needed to 
quickly determine if maggots found inside of a body bag were the same as the pupae 
found on the floor under the corpse (Benecke, 1998). There was not enough time to let 
the pupa grow, so DNA testing was needed. Results of RAPD analysis showed the 
arthropods being compared were genetically identical, and the testing was considered 
successful (Benecke, 1998). Another example of the use of RAPD in forensic science 
occurred in May of 1992. A female was found dead under a Palo Verde tree in Arizona 
and a pager was found nearby. The pager was linked to Mark Bogen and he became the 
number one suspect, but the investigator needed more evidence that would place him at 
the scene of the crime. When they investigated the suspect’s truck they found seed pods 
from a Palo Verde tree. One of the only ways to prove that the pods were from the same 
tree that the victim was found under was through DNA analysis, but no past genomic 
information was known about the Palo Verde tree. That is when the forensic scientist 
decided to use the RAPD procedure. Based upon testimony from Tim Helentjaris, and Dr. 
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Paul Keim, associate professor at the University of Arizona and professor at Northern 
Arizona University respectively, the evidence was allowed in court for the first time. Dr. 
Keim did testify about the downfall of RAPD stating that the procedure is not completely 
reliable or reproducible. Due to this testimony statistical evidence was not allowed in 
court but that did not seem to hinder the evidentiary value of the RAPD profiles for the 
jury. Dr. Helentjaris was allowed to testify that the DNA RAPD pattern of the seed pod 
was indistinguishable from the reference pattern obtained from the tree the victim was 
found under. The suspect was convicted of the murder based on upon the DNA and 
physical evidence and he was sentenced to life without the possibility of parole (Rudin 
and Inman, 2002).
The advantages of RAPD are that only a small amount of template DNA is needed, a 
specific primer is not needed, the sequence of the genome of the organism does not need 
to be known, and the procedure is relatively easy, quick, and inexpensive. Some 
disadvantages include the possibility of contamination and the fact that it is extremely 
sensitive to the reaction conditions which can compromise reproducibility (Treuren, 
2000). 
Agarose gel electrophoresis is the technology that has generally been used to separate the 
RAPD-DNA fragments produced. Thus, tracing the source of a DNA sample relies upon 
matching the spatial arrangement of polymorphic DNA fragments produced by RFLP 
analysis or PCR (figure 7). The agarose gel used for DNA fragment separation is a semi-
solid matrix that has pores acting as a molecular sieve. The DNA is loaded into the gel 
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and migrates based on size to the anode when a direct current applied. Along with RAPD 
products, a ladder representing different size standards are often run in the gel so the 
unknown DNA can be characterized by size. Visualization of DNA in the gel often 
occurs following staining the gel with ethidium bromide and illumination with UV light 
(Butler, 2001). 
Capillary gel electrophoresis (CE) has replaced the older slab gel electrophoresis 
technology in most forensic labs in the United States. Capillary electrophoresis is most 
often performed as part of automated DNA analysis systems like the ABI Prism 310 
Genetic Analyzer that was introduced in 1995 by Perkin Elmer-Applied Biosystems 
(Foster City, CA). CE normally incorporates laser-induced fluorescence (LIF) to detect 
DNA fragments. Visualization of DNA profiles with LIF is more sensitive, easily 
automated, and is less toxic than the ethidium bromide used to visualize DNA in slab 
gels. In the capillary based methods, each amplified DNA product is labeled with a 
fluorescent dye (attached to one or more primer) and separation of fluorescent DNA 
molecules occurs in the capillary containing a sieving polymer (310 Genetic Analyzer 
Performance Optimized Polymer 4, PE Applied Biosystems, Foster City, CA). 
Fluorescent products are excited by the laser and a CCD, or charge-coupled device, 
camera will capture those emissions as the sample migrates through the capillary and 
passes a small window through which the laser enters. The genetic analyzer is interfaced 
with a Macintosh computer that stores electrophoretic and fluorescence data (Relative 
Fluorescent Units, or RFUs) to produce an electropherogram. The raw data can then be 
analyzed with a specialty software (Genescan or Genotyper) to create an easily analyzed 
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DNA profile for each sample that can be compared with the profiles produced from other 
samples (Butler, 2001).
Figure 7.  Representation of  a Capillary Electrophortic Device (Butler, 2001). 
CE has many advantages over slab gel electrophoresis including the fact that many of the 
steps are automated and thus can be run unattended. A smaller amount of sample is used 
and higher voltage (due to the small surface area of the capillary) is used allowing for the 
separation of DNA products in minutes rather than the hours required for slab gel 
electrophoresis. Another advantage is that the additional steps needed to analyze the gel 
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are not performed when using capillary electrophoresis and cross-contamination that can 
occur in gels is eliminated in the capillary. The final advantage is that capillary 
electrophoresis results are interpreted more precisely by a computer program, unlike the 
human generated results that accompany analysis of a slab gel. This allows for better 
reproducibility and the ability to estimate quantities of PCR products based on the 
amount of fluorescence produced (RFUs). One of the disadvantages is that since the 
samples are analyzed one at a time the throughput is not as high as a slab gel that can 
separate as many as 100 samples at once (Butler, 2001). 
Presently, identification of bacteria through the use of morphological and physiological 
tests are the most commonly used to determine if a specimen is B. anthracis. The CDC 
produced a protocol for Level A Laboratories for the presumptive identification of B. 
anthracis. The protocol gives a flow chart of what testing a lab needs to do with a 
suspected B. anthracis sample. It states what specimens are to be collected from a human 
patient based on the type of anthrax suspected. For example, if inhalation anthrax is 
suspected, the lab is to collect blood or sputum from the lower reparatory tract. A Gram 
stain test is performed to look for large, Gram positive rods (Figure 8). A smear of the 
specimen is also performed and short chains of encapsulated bacteria are suggestive of B. 
anthracis (Morse, 2002).  
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Figure  8. Gram Stain of B. anthracis (Morse, 2002). 
Labs are also instructed to grow the bacterium on sheep’s blood agar to look for 
hemolytic activity and also for the presences of oval intracellular spores within long 
chains of bacilli. Culture tests are to be performed including inoculating and streaking 
different plates at 35oC with reading of the plates occurring daily for 3 days. Motility is 
tested on a wet mount slide to look for nonmotility because B. anthracis is nonmotile, 
this can be determined within 1-2 days. Table 2 provides a list of all approved tests for 
the detection of B anthracis.
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Laboratory Level approved
 to perform test
Test Procedure A B C D
Gram Stain X X X X
Capsule (Indian Ink) X X X X
Routine culture:
Colonial morphology X X X X
Hemolysis X X X X
Motility X X X X
Sporulation X X X X
Confirmatory test:
Lysis by gamma-phage X X X
Direct fluorescence assay (DFA) X X X
Antimicrobial susceptibility testing X X
Advanced technologies (PCR) X X
Molecular characterization X
Table 2. CDC’s approved test for Detection of Bacillus anthracis in the Laboratory Response Network 
(LRN) (Approved tests, 2001).
 The CDC recommends that at least two of these tests be performed with results showing 
that the bacterium is not B. anthracis before it is ruled out (Morse, 2002). If it has all the 
features of B. anthracis it is to be reported as stated in the following protocol; 
Reporting/action 
a. Consult with state public health laboratory director (or designate) if B. 
anthracis is suspected. 
b. General instruction and information 
(1) Preserve original specimens pursuant to a potential criminal investigation 
and possible transfer to an appropriate LRN laboratory. 
(2) Environmental/nonclinical samples and samples from announced events
 are not processed by Level A Laboratory; submitter should contact the 
state public health laboratory directly. 
(3) The state public health laboratory/state public health department will 
coordinate notification of local FBI agents as appropriate. 
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(4) Assist local law enforcement efforts in conjunction with guidance 
received from the state public health laboratory. 
(5) The state public health laboratory/state public health department may 
request transfer of suspicious specimens prior to presumptive testing. 
(g) FBI and state public health laboratory/state public health department 
will coordinate the transfer of isolates/specimens to a higher-level LRN 
laboratory as appropriate; refer to Shipping Procedure. 
c. Immediately notify state public health laboratory director (or designate) and 
state public health department epidemiologist/health officer if B. anthracis 
cannot be ruled out and a bioterrorist event is suspected. 
d. Immediately notify physician/infection control according to internal policies 
if B. anthracis cannot be ruled. 
e. If B. anthracis is ruled out, proceed with efforts to identify using established 
procedures (Morse, 2002).
When the CDC receives samples of suspected B. anthracis they perform their own 
morphological testing and ELISA (Enzyme Linked Immunosorbent Assay) testing. The 
morphological tests generally take approximately twelve to twenty-four hours (CDC’s 
Laboratory Response to Suspicious Substances, 2004; J. Schwendinger, personal
communication, June 6, 2005). ELISA is a conformation test that detects the 
immunoglobulin G (IgG) response to B. anthracis protective antigen (PA). This test is 
sensitive, has been shown to be very reliable, and can be performed in one hour. ELISA 
is approximately 80% specific, so to improve specificity, the CDC added an anti-PA IgG
competitive inhibition ELISA as a second confirmatory step (Clinical issue, 2002). The 
anti-PA IgG ELISA is a direct extension of the standard ELSIA that utilizes different 
antibody concentrations. These two ELISA tests allow for rapid, sensitive, and specific 
detection of B. anthracis in human patients (Quinn et. al., 2002). Another test that the 
CDC performs to detect anthrax is a general PCR test that uses primers created 
specifically for B. anthracis. An example of primers used are ones that complementarily 
pair to loci in the 16S rRNA gene. This test, among a battery of such tests, takes 3-5 
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hours each and allows the CDC to detect specific strains of disease agents efficiently 
(CDC’s Laboratory Response to Suspicious Substances, 2004; J. Schwendinger, personal 
communication, June 6, 2005).
During the anthrax mailing attacks of 2001, a procedure coined the “Keim Technique” 
played an important role in subtyping and identifying strains of Bacillus anthracis
(Hoffmaster et. al., 2002). Keim testing uses multiple-locus variable-number tandem 
repeat analysis (MLVA) to examine the relationships among isolates of B. anthracis. The 
Keim assay uses RFLP analysis of eight VNTR loci located in the genome of anthrax. 
Among 426 different isolates of B. anthracis, only 89 distinct genotypes were identified, 
underscoring the genetic similarity of the species (Keim et. al., 2000). This procedure is 
used by the CDC because it proved to be useful in confirming that all isolates involved in 
the attacks of 2001 were the same strain (Hoffmaster et. al., 2002). Over 100 different 
strains of B. anthracis with distinguishing DNA fingerprints have now been found. At 
present however, these test are not considered confirmatory (Anthrax Q & A: Laboratory 
Testing, 2004). The tests take the CDC approximately six to eight hours to subtype 
bacteria whose genome is known (J. Schwendinger, personal communication, June 6, 
2005).
Along with this procedure, Read et. al. (2002) used whole-genome analysis of the strains 
isolated from the victims of the attacks, and found 60 new DNA markers that included 
SNPs, or single nucleotide polymorphisms as well as the tandem repeats discussed above. 
These markers allow the bacterium to be divided into distinct families. DNA analysis 
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procedures are believed to help in the future investigation of infectious disease outbreaks 
when the genomic sequences of the agent are known. 
The goals of this study include:
1) Determining if the Random Amplification of Polymorphic DNA method, or RAPD 
method, can be used in conjunction with capillary electrophoresis platform.
2) Determining if differences can be found using RAPD analysis between Bacillus and 
non-Bacillus bacteria.
3) Determine if differences can also be found using RAPD between Bacillus cereus and 
other Bacillus species.
4). The development of a working, reproducible procedure for the strain differentiation 
among isolates of Bacillus cereus.
5) Determining if RAPD can be used to match unknown forensic samples to each other.
The ultimate aim of the study was to develop a procedure that could be used to efficiently 
link forensic samples to each other. This is the same goal as would be in any other 
discipline of forensic science. The goal of fingerprint analysis is to match a suspect to a 
fingerprint left at a scene, the goal of document examination is to link a suspect’s known 
writing sample to that on a questioned document, and when a fiber or hair is found at a 
scene of a crime the goal is to link that hair or fiber back to a suspect. During the anthrax 
mailings of 2001, it was important for investigators to know if all of the letters had been 
sent from one source, or if more than one source was involved in the attacks, and what 
was the origin of the source.  This was eventually accomplished but was time consuming, 
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due to the fact that the complete genome of the Ames strain of B. anthracis had not yet 
been determined, and was not completely sequenced until May of 2003 (Read et. al.,
2003). The aim of this project was to use the RAPD procedure in a mock terrorist attack 
to link isolates of B. cereus to each other and to an origin efficiently and effectively.
2. Material and Methods
2.1 Sample Selection
Soil samples were collected along Interstate 35 in Oklahoma, which is considered the 
horticultural dividing line of the United States. The top one inch of soil was collected 
every ten miles between Tulsa and Enid, Oklahoma.  Soil samples were also obtained 
from sporting fields, including the football practice field of Oklahoma State University in 
Stillwater, Oklahoma.  
Bacillus microbes were cultured from the soil samples by pasteurization at 70oC in order 
to eliminate other unwanted bacteria present. The bacteria were plated on sheep’s blood 
agar (SBA) and mannitol-yolk-polymyxin (MYP) plates. The plates were incubated at 
38oC for 24 hours and examined morphologically to identify candidate bacterial colonies 
representing B. cereus. B-hemolytic patterns on SBA, microbial interaction on MYP, 
production of lecithinase, and API test strips were all used to determine which colonies 
were B. cereus. Colonies positively identified as B. cereus were harvested with a loop 
and re-plated to obtain a pure culture. Gram staining was preformed to confirm the 
presences and purity of B. cereus isolates (Miller, 2005) . 
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2.2 Growth for DNA isolation
A loop of a particular B. cereus strain was inoculated into a labeled tube containing 2mL
of prepared Mueller-Hinton Broth (Becton, Dickinson and Company, Sparks, MD) . The 
tubes were placed in an incubator-shaker overnight at 37oC with continual shacking to 
produce a stationary phase culture. Following incubation, each sample was centrifuged at 
7000 xg for five minutes at room temperature to obtain the cellular pellet. The media was 
carefully removed as not to disturb the cell pellet.
2.3 DNA Extraction
The extraction of DNA from Gram positive bacteria is complicated by the fact that the 
cell wall (which contains D-amino acids) is resistant to proteolysis and must be disrupted 
mechanically to facilitate release of the DNA. In this method the combination of 
chemical and mechanical disruption liberates DNA from the cell. 35uL of 20% Sodium 
dodecyl sulfate, 25uL of  20mg/mL Protease K( in 10mM Tris-Cl, 20mM CaCl2, 50% 
Glycerol), 440uL of TNE(10mM Tris-Cl pH8.3, .2M NaCl, 1mM EDTA), and .05g of 
glass beads (Sigma Chemical Company, St. Louis, Missouri), were added to each 
bacterial cell pellet. Cell pellets were resuspended and incubated at 65oC with vigorous, 
intermittent vortexing throughout the hour long incubation.  
Extracts were then subjected to organic extraction with an equal volume of 
phenol:chloroform/isoamyl alcohol (9:0.96:0.4 v/v). Phases were separated by 
centrifugation at 8,000 xg for one minute at room temperature. The top, aqueous layer, 
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which holds the genetic material, was removed and added to a new, labeled tube. The 
sample was then extracted with an equal volume of chloroform:isoamyl alcohol (24:1 
v/v) followed by centrifugation to separate the phases. The top aqueous layer was again 
removed and added into a new clean, labeled tube. 
A commercial kit called DNA Clean and Concentrator TM -5 (Zymo Research, Orange, 
California) was use to obtain pure and concentrated DNA. The kit uses a binding buffer 
with a high salt content to promote binding of the DNA to silica particles in a small 
column. This binding buffer was added at 2:1 parts of buffer to each DNA sample. That 
mixture was then added to the silica column and the samples were centrifuged at room 
temperature at 10,000 xg for 10 seconds. As a sample is forced through the column, the
DNA binds to the silica but allows all others components in the sample to pass through
and collect in the bottom of a microfuge tube. The flow through produced was considered 
waste and was discarded. 200ul of the Wash Buffer, provided with the kit, was added to 
each filter followed by another round of centrifugation at room temperature for 10 
seconds. The wash step was repeated one more time with the centrifugation time being 
raised to 30 seconds, and the wash fluid was also discarded.
Heat and TE-4 (10mM Tris-CL pH 8, .1mM EDTA) was used to elute the DNA from the 
silica column. The column apparatus was placed into a clean, labeled tube, and 15uL of 
TE-4 stored at 65oC was added. The tube/column was then heated for one minute at 65oC 
and centrifuged at 10,000 xg for 10 seconds at room temperature. This process was
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repeated again and both 15ul elutes were combined into a single collection tube. DNA 
was stored at 4oC until further use.
2.4 DNA Quantitation
The amount of DNA obtained from each bacterial sample varies and must therefore be 
quantified. This was accomplished using a .8% agarose yield gel. The gel was made by 
adding 0.6 grams of agarose (Sigma-Aldrich, Inc. St. Louis, Missouri) into 75mL of 1 X 
TAE buffer (900-1000ul dH2O, 48.4g Tris, 11.4mL Glacial Acetic Acid, 20mL .0.5 M 
EDTA). The agarose-buffer mixture was put in a microwave and heated, swirling 
frequently, until the agarose melted. The molten agarose was cooled to about 50oC, 
poured into a mold containing a sample well comb, and allowed to set at room 
temperature until it has hardened (usually 15-30 minutes). 
In order to determine the quantity of DNA in the bacterial extracts, known quantities of a 
reference DNA were electrophoresed alongside given volumes of the unknowns in the 
yield gel. Five quantitation standards containing different amounts of Lambda
bacteriophage DNA (United States Biochemical, Cleveland, Ohio ) were prepared in 1 X 
TAE containing electrophoresis loading dye (bromphenol blue, xylene cyanol, 5X TAE 
w/ 25% Ficol), and distilled water as described in Table 3.
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Total Concentration
Obtained
Amount of Lambda 
DNA
Amount of Loading 
Dye
Amount of Distilled 
Water
500ug/uL 2uL 23uL 0
250ug/uL 1uL 24uL 0
125ug/uL 0.5uL 24uL 0.5uL
62.5ug/uL 0.25uL 24uL 0.75uL
31.25ug/uL 0.125uL 24uL 0.875uL
Table 3. Description of how size standards were produced for use in the yield gel to aid in the estimation of 
the amount of DNA present in the sample. 
The agarose gel was placed into the gel box and enough 1X TAE Buffer to cover the gel
(approximately 800mL) was added. Samples were loaded individually into the wells of 
the gel and electrophoresis was initiated at 50 volts until the samples entered the gel and 
then the voltage was increased to 75 volts. Electrophoresis was continued until the 
samples migrated half way down the length of the gel (approximately two inches), which 
required approximately one hour. 
DNA was visualized in the gel after ethidium bromide staining (0.2% in dH2O, J.T. 
Baker, Phillipsburg, NJ) and illuminated with a UV light. The gel and running buffer 
were placed into a baking dish along with 100ul of ethidium bromide. The ethidium 
bromide interacts within the DNA helix and fluoresces when illuminated with UV light.
A digital picture was taken of the illuminated gel through an orange filter and used to 
compare the fluorescence of the standards to the unknowns to estimate  the amount of 
DNA present in each extract (Figure 9).
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Figure 9. Photograph of a yield gel used in this study. The first 5 wells are the standards. The next well is 
empty. The next four rows are different isolates of DNA. An estimate of amount of DNA is made based on 
the intensity and width of the band. For example isolate number one is slightly larger than the standard for 
500ug/uL, so it is estimated that its concentration is 550ug/uL.  
2.5 Amplification
PCR reactions were prepared from stocks of concentrated components diluted with 
distilled water to achieve the desired concentration. A primer concentrate was made that 
contained equal molar amounts of each of the five primers used for the RAPD procedure. 
The mixture contained 1uL of each primer at 100uM concentration mixed with 20uL of 
TE-4, which produced a final primer concentration in the stock of 10uM each. Some of 
the random oblionucleotide primers used were chemically linked to fluorescein, and 
therefore amplicons produced with these primers were fluorescently labeled. The five 
RAPD primers consisted of the following sequences:
      1.   5’- fluoresceine –GGGTAACGCC-3’
2. 5’-fluorescein – GTGATCGCAG – 3’
3.  5’-fluorescein – AGCCAGCGAA -3’
4. 5’-CACACACACACACACARG-3’ (R= can bind to Adenine or Guanine)
5. 5’-CACACACACACACACARY-3’  (Y= can bind to Cytosine or Thymine)
Bacterial DNA recovered from each bacterial strain was diluted with distilled water in 
order to obtain a concentration of approximately 20ng/uL. Each PCR reaction was 
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programmed with 20ng of DNA sample (in 1 uL) along with 11.5ul of master mix
consisting of primers, nucleotide triphosphates, Taq DNA polymerase, and buffer 
components, producing a total volume of 12.5ul (Figure 10). The master mix was 
composed of 8.5uL of dH2O, 1.25uL Gold Star 10X Buffer (Promega, Madison, 
Wisconsin), 1.25uL of the prepared primer mix, and .25uL of Taq Gold (Applied 
Biosystems, Foster City, California) for each sample. A blank was also amplified, 
prepared with 1ul of distilled water rather than DNA.
Figure 10. PCR set-up spreadsheet. Example of how the PCR reactions are calculated.
All samples were amplified with a PTC-200 thermalcycler (MJ Research, Las Vegas, 
NV). The cycling program consisted of 1 cycle at 95oC for 11minutes, followed by 44 
cycles of 94oC for 1 minute, 40oC for 1 minute, and 72oC for 2 minutes. A final cycle of 
72oC for 45 minutes was added to complete product elongation and minimize the 
variability of the added 'Adenine' nucleotide that occurs slowly following the completion 
of each cycle.
2.6 Electrophoresis
Following amplification, amplified products were analyzed utilizing capillary 
electrophoresis in a Prism ABI310 Genetic Analyzer (Applied Biosystems, Inc. Foster 
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City, California). An internal size standard added to each sample allowed for automated 
sizing of amplicons in each electrophoretic run and to normalize the patterns across 
multiple runs. Each sample consisting of 5ul of amplified product had .5ul of the internal 
size standard, Genescan ROX 500 (Applied Biosystems, Foster City, California), added 
along with  24.5uL of Hi-Di Formamide (Applied Biosytems). The samples were heated 
at 95oC for 3 minutes to denature the double stranded DNA and then immediately put in a 
frozen ice block to quickly chill the samples. The samples were placed into the ABI 310 
sample tray and electrophoresed in succession. Each sample was electrophoresed for 32 
minutes in order to allow for the detection of high molecular weight amplicons produced 
from bacterial samples. Raw electrophoresis data was analyzed using Genescan software 
to compute fragment sizes and quantitiate fluorescence. RFU, or relative fluoresence 
units were measured by the CCD camera as labeled PCR products pass the detection 
window in the capillary. Size estimates and fluorescence intensity were shown together in 
a GeneScan printout known as an electropherogram.
2.7 Data Analysis
Electropherograms allow an investigator to determine the size (in base pairs, or bp) of 
each product amplified from a template and an estimate of amplicon quantity reflected in 
the total RFUs in each PCR product. Electropherograms can be visually compared with 
one another to determine similarities and differences in the sizes and amount of products 
produced from different DNA templates. For this study, PCR products were also grouped 
into sized bins of 10bp over the entire size range spanned by an electropherogram (100bp 
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to 500bp). If there was at least one product in a 10bp size bin, then that bin was scored 
for a particular bacterial isolate. Thus matching the DNA profile produced from different 
strains of bacteria depended in large measure on the spatial relationship of PCR product 
sizes in narrowly defined size categories.  
3. Results
3.1 Strategy of the RAPD procedure
The goal of this study was to evaluate the feasibility of using RAPD analysis methods to 
develop genetic profiles for different isolates of bacteria. It was important to develop a 
RAPD procedure that would produce DNA profiles with sufficient polymorphic 
complexity that a differentiation among strains of bacteria could be determined, but yet 
not be so complex as to make comparisons impossible. Initial experiments were 
performed to examine different steps in the RAPD procedure used in conjunction with 
the 310 Genetic Analyzer. The nature of RAPD analysis is such that mixtures of arbitrary 
primers direct the amplification of genomic DNA targets under conditions of low 
stringency. Thus, it was imperative to evaluate different primer combinations and to 
fastidiously control temperature during cycling to generate reproducible DNA profiles. 
Each aspect of the RAPD procedure was evaluated in turn to develop conditions that 
would produce DNA profiles that were reproducible. 
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3.1.1 Primer Investigation
Identification of suitable primers involved testing individuals or mixtures of each of five 
different primers available with DNA extracted from two morphologically distinct
isolates of B. cereus. The nucleotide sequences of three of the primers evaluated were 
chosen because they had previously been shown to be useful in the RAPD method with 
DNA obtained from soil bacteria (Babalola et. al., 2002). The other two primers 
evaluated exhibited redundancy at the 3’end to enhance their ability to direct 
amplification of a wider collection of genomic DNA targets and were included in the 
study simply because they were available in the laboratory.
Each primer alone directed amplification of only a few DNA products, if they produced 
any at all. Thus, the use of a single primer would not direct the amplification of a 
sufficiciently complex DNA profile to distinguish strains of B. cereus (Figure 11).
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Figure 11. Single primer experimentation  results. Electropherogram of the strain Arnold amplified with a 
single primer, shown with the internal standard (in red). P1 is the primer sequence GGGTAACGCC, P2 is
GTGATCGCAG, and P3 is AGCCAGCGAA. As shown, these profiles were not complex enough to create 
a profile suitable to distinguish strains from each other. 
In addition to single primers, mixtures of subsets of primers also did not produce DNA 
profiles of suitable complexity (not shown). However, a mixture of all five primers
(figure 12) did produce DNA profiles that were sufficiently complex to allow two strains 
of B. cereus (Arnold and Whimpy) to be easily distinguished (Refer to section 3.2 on 
page 39 for more information about these strains). 
Figure 12. Electropherogram produced with all five primers on a reference strain of bacteria. These primers 
provide a  profile sufficiently complex enough to allow for strain comparisons.  
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3.1.2 Annealing Temperature Investigation
Due to the fact that RAPD primers do not target specific, predetermined loci in genomic 
DNA, the annealing temperature used in the PCR cycling is important. PCR primers bind 
tightly to a DNA target that is perfectly complementary. In the RAPD method however, 
primers are usually not perfectly complementary, but may be sufficiently related to 
targets in a template to direct amplification of products at a low annealing temperature.
Therefore, it was important to determine which annealing temperature gave the most 
reproducible DNA profile consisting of an adequate number of polymorphic products. 
This was empirically determined by varying the annealing temperature in the cycling 
program and seeing which appeared to produce the most reproducible and sufficiently 
complex profiles. Throughout testing, the optimal temperature was 40oC, which was used 
for the rest of the experiments (not shown). 
3.1.3 Primer Dimer Test
A blank was included in each analysis to serve as a negative control to show that samples 
were not contaminated. Several small PCR products were typically visible in the 
electropherogram of the blank. A test was performed to determine if these products were 
produced by contaminating DNA, or resulted from a phenomenon called primer dimer.
This is caused when primers bind to each other, are amplified, and produce a product.
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Figure 13. Evidence of the phenomenon, primer dimer, occurring. Small molecular weight products (in 
blue), most occurring under 80bp (sizes listed across the top of the electopherogram), were produced in 
ever blank sample. Suggesting that primer dimer has occurred.
Product sizes # of products
50-59 6
60-69 5
70-79 2
80-89 7
120 1
Table 4. Size and average amount of products produced due to primer dimer.
Figure 13 is an example of the primer mix directing the amplification of products of low 
molecular weight in the absence of added DNA template. These low molecular weight 
products, listed in Table 4, appear to be primer dimers for several reasons:
1.) The products are typically small, exhibiting molecular weights of less than 100bp.
2.) They are produced in the absence of any added DNA template. Even sterile distilled 
water will result in their production.
3.) Amplification containing single primers or subsets of primers lack the products 
produced when all five primers are used together.
4.) Raising the annealing temperature during PCR cycling reduces the complexity of the 
low molecular weight products produced.
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Due to the fact that primer dimer products generally (with the exception of the 120bp 
product) only occurred under 90bp, only products larger than 100bp were used for 
analysis. 
3.1.4 Reproducibility Investigation
Since RAPD is an extremely sensitive procedure, variability in any step in DNA 
extraction or PCR amplification can affect the qualitative or quantitative nature of 
products produced. Therefore it is important that there is reproducibility in the DNA 
profiles produced from DNA extracted from a given strain of bacteria. Testing was done 
to determine if within the same run of the ABI Prism 310 Genetic Analyzer, a single 
bacterial isolate would produce the same DNA profile when repeatedly amplified. Then 
the same test was performed when the isolates were analyzed on different days. The 
results show that there is some variability both within and between runs on the genetic 
analyzer, but the variability did not preclude profile comparisons. As shown in Figures 14 
and 15, most of the variability is quantitative in nature. 
39
Figure 14. Evidence of  reproducibility within the same run. The profiles that are shown were produced 
from genomic DNA extracted from the Arnold isolate. The peaks are all qualitatively the same, the only 
difference being the amount of product present as represented by the relative fluorescence, or RFUS, in 
each PCR product. These two profiles show that they are from the same isolate of bacteria.
Figure 15. Evidence of reproducibility between different runs. The profile produced is very similar to the 
profiles produce in figure 14, and can be shown to be the same strain as the isolate in figure 14.
3.2 Isolate Differentiation 
Two morphologically different isolates of B. cereus were selected to be the controls for 
the project and represent extremes in DNA profiles produced with B. cereus genomic 
DNA. One strain, named Arnold, exhibited phenotypic properties suggesting it would be 
the most toxic if one were infected with it. The Arnold strain also exhibits the most 
complex RAPD profile. The other strain, known as Whimpy, exhibits a phenotype 
suggestive of very few toxins and also exhibited a very simple RAPD profile. Their 
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profiles were easily distinguishable from one and another and thus represent extremes of 
DNA RAPD profiles for B. cereus (Figure 16).
Figure 16. B. cereus strain vs. B. cereus strain. Electropherogram of Arnold in blue and Whimpy in red 
showing the differences in the profiles. Some of the products were shared, such as the 380bp product, as 
would be expected in related isolates.  
The two references DNA were also compared based on the average products that were 
produced. The binning of these products underscores the significant difference in RAPD 
profiles between the two strains (Table 5). 
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Product 
Size(s) 
(base pairs)
Arnold Whimpy
100-119 X X
150-159 X
160-179 X X
180-189 X
190-199 X X
200-219 X
220-239 X
300-309 X
320-329 X
350-359 X
380-399 X X
410-419 X
450-460 X
Over 500 Avg. 6 
products
Avg. 5 
products
Table 5. Binning of products produced in RAPD analysis. Products are placed in size bins of 10 to 20 base 
pairs. There are generally multiple products of slightly differing size occupying each bin. All products 
listed appeared in over 77% of runs. These two isolates became the reference phenotypes that profiles 
produced from unknown isolates were compared against during the rest of the experiments.
For any molecular assay to be useful for the identification of a bioterrorist agent, it must 
be able to distinguish closely related strains of organisms. In the case of anthrax 
identification, a molecular assay must be able to distiquish between B. anthracis and non-
Bacillus species as well as different species of Bacillus and ideally even different strains 
or isolates of the same species of bacteria. The RAPD profiles produced with DNA from 
reference strains of B. cereus were compared against other Bacillus isolates shown 
morphologically to be non-B. cereus.
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Figure 17. Non-B.  cereus isolate electropherogram.  Arnold and Whimpy (in blue) are the two reference 
samples that are examples of B. cereus.. The green, 5B, and red, 27C, are isolates that were known to be 
Bacillus species, but were not B. cereus as determined by morphological and physiological criteria. 
Figure 17 provides evidence showing the RAPD profiles of non-B.cereus species are
distinguishable from that of B. cereus, but can look similar as does sample 27C and
reference sample, Whimpy. Isolate 5B exhibits clear similarity to the Arnold strain and 
yet harbors clear differences in the genome that are revealed through the RAPD 
procedure. If the Arnold strain and 5B strains were recovered from separate disease 
Reference
Arnold
Non- B. 
cereus
Non- B. 
cereus
Reference
Whimpy
43
outbreaks thought due to bioterrorism, one could possibly conclude the infectious agents 
responsible for the outbreaks originated from related, yet distinct sources. 
Figure 18. Non-Bacillus isolates electropherogram. Profiles of Bacillus cereus Arnold and Whimpy are 
shown again as reference to compare non-Bacillus isolates. The green profile, A, and the black profile, D, 
are isolates of bacteria that are not Bacillus.  
In figure 18, RAPD profiles produced from non-Bacillus species are compared to the 
reference B. cereus strains, Arnold and Whimpy. The isolate labeled D shows a very 
different profile from either of the reference isolates. The other non-Bacillus isolate is 
distinct, but not as clearly as the isolate labeled D. It does have products that are sizes 
different than any B. cereus isolates, like the products in the 200-300bp range.  Some 
products were shared by isolate A and Arnold, like the 460bp product. This might suggest 
there is some relatedness at the DNA level between the isolates, or it could just be a 
coincidence that the DNA from the different isolates directs the amplification of distinct 
products of similar size.  Recall the RAPD procedure is useful because one need not 
Non-
Bacillus
Reference
Whimpy
Non-
Bacillus
Reference
Arnold
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know any DNA sequence of a target and thus products of identical size may consist of 
unrelated nucleotide sequence. 
3.3 Mock Forensic Investigation
A mock forensic investigation was performed to test the RAPD procedure. In an actual 
attack a terrorist could use any number of different methods to deliver an infectious agent 
including mailing spores to selected targets like the attacks of 2001. Other possible 
transmission routes exist and in a recent study from this graduate program (Miller, 2005), 
B. cereus spores were inoculated into coffee grinds that were subsequently brewed, were 
inoculated onto a toothbrush, and were sprayed onto doorknobs. In every case, viable 
bacteria could be cultured from the spores, demonstrating the potential for success in 
infecting a human target with anthrax. These scenarios of mock bioterrorist attacks also 
afforded an opportunity to challenge the RAPD assay to identify the strains of B. cereus
used to inoculate the different items. Seven isolates of B. cereus from which the strains 
used in the mock attack were derived were tested using RAPD and the resulting DNA 
profiles were used as a reference database (Figure 19).
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Figure 19. Electropherograms of the seven reference used in the mock forensic attack. 
Two of the seven isolates were chosen to be used for the coffee scenarios and to spray the 
doorknobs. The spores recovered from the brewed coffee and from the doorknob were
cultured in order to produce sufficient cells to be analyzed using the RAPD procedure.
RAPD profiles produced from isolates from the coffee and doorknob  were compared 
against the database of RAPD profiles from the seven reference strains through simple
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visual comparison and matching of the binning of main PCR products found in each of 
the isolates (Figure  20).
Figure 20. Products produced during RAPD analysis used in the bioterrorist experiment. Colored horizontal 
bars indicate the presence of PCR products grouped into size categories expressed as 10bp or 20bp ranges 
and listed across the top of the figure. The isolates recovered from brewed coffee are labeled Coffee 1 and 
2 respectively (CU1 and CU2). The isolates cultured from spores sprayed on to the doorknobs are labeled B 
and C. Reference and unknown strains believed to be identical based upon their RAPD profiles are 
indicated with horizontal bars of the same color.
The two different isolates were used in both the coffee and doorknob test and in each case 
the references samples could be matched to each ‘attack,’ linking them to each other and 
a common source. The RAPD profiles recovered from bacteria used to inoculate coffee 
and to spray doorknobs show clear relatedness to reference strains #3 and #5, respectively 
(Figure 21). After consulting with the investigators who produced the attack experiment,
it was learned that the correct identification of the unknowns had been made by the 
RAPD procedure. 
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Figure 21. Electropherogram of linked isolates. Bacteria obtained after brewing the coffee and bacteria 
obtained from the doorknob were able to be linked to each other. They both were able to be linked to a 
references isolate, determining the origin of the bacteria. The green profiles are one of the seven isolates 
that were given as a reference profile. The blue profile is the isolate that was obtained from the mock coffee 
pot attack. The red profiles were the isolates obtained from the doorknobs.
Figure 21 shows that the reference (#3) matched the strain from the coffee pot (CU1) and 
one from the door handles (B). Likewise, Reference strain #5 matches the other isolates 
from the coffee pot attack (CU2) and door handle attack isolate (C). RAPD profiles from 
a common source are superimposed on one another to demonstrate similarities and 
Reference 3
Coffee 1
Doorknob B
Reference 5
Coffee 2
Doorknob C
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quantitative differences (Figure 22). Quantitatively the strains differ, which could be due 
to unequal concentrations of template DNA, but qualitatively the products produced are 
ultimately the same and these isolates can be said to be from the same strain of bacteria. 
Figure 22. Superimposed electrpherogram of  linked isolates. The two isolates used in the experiments and 
the references sample that was determined to be the origin of the attack, all were found to be identified. The 
reference isolate is in green and its profiles matches closely the profile of the isolate from the coffee, shown
in blue and that produced from the door knob isolate (in red). 
4. Discussion 
4.1 Review of Results
Investigators need a reliable way to link terrorist attacks to each other or back to an 
original source. It is important that in a bioterrorism attack, separate outbreaks of 
infection can be quickly analyzed to link the outbreaks to a single infectious agent. This 
would help investigators determine if one source or multiple sources of agents were 
responsible. Genetic analysis of a bacterial strain can also help determine the origin of the 
bacteria. This occurred during the 2001 attacks, when it was determined, through genetic 
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analysis, that the anthrax strain used was identical to Ames strain. The Ames strain
originated in the United States and was named for a strain that was isolated from cows in 
Ames, Iowa in the 1930’s (MacKenzie, 2001).  Genetic analysis also showed a high 
degree of homology between strains used in research and the strains used in the attack, 
suggesting the strains were not separated by many or any generations (MacKenzie, 2002). 
Al this information  assisted investigators in their investigation of this crime. 
The RAPD method provides a relatively quick, inexpensive, and reliable way to compare 
the DNA profiles of strains of bacteria. After extraction of DNA, this procedure can be 
accomplished in 5-8 hours. The faster such information becomes available, the faster an
investigation can move forward to hopefully prevent further attacks. Moreover, with 
more research, if the CDC and state laboratories were to develop databases of RAPD 
profiles for strains of bacteria possibly used as a bioweapons, public health investigators 
could compare the profiles in the database against an isolate recovered from a suspected 
attack and perhaps identify the bacteria. When anthrax was sent through the mail in 2001, 
researchers had to test each sample against all strains known to be used in different 
countries. If there would have been databases the samples could have been tested quickly 
and the researchers would have known quickly that the strain used in each attack was the 
same, and from the American strain known as Ames.   
The RAPD procedure developed in these experiments, could allow for strain 
differentiation among Bacillus species. It was also effective in revealing distinctions at 
the DNA level between B. cereus strains and non-Bacillus species. Most importantly, it 
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allowed for strain matching among different isolates of B. cereus, which, overall, exhibits 
a high degree of DNA sequence homology. During the testing it became apparent that 
many of the different strains shared some of the same products, as would be expected 
from related organisms. However, there was enough variability among the strains to 
differentiate them and be confident in matching strains to each other, to a reference, or to 
an original source. 
Some of the isolates of bacteria were very similar in the products that they produced with 
the RAPD procedure. For example, in Figure 24, isolates labeled as 4 and 5 are shown in 
electropherograms. They show many of the same products, suggesting close relatedness, 
but there are high molecular weight products that isolate #5 possesses that isolate #4 does 
not. This information allowed the two strains to be distinguished, which was informative 
for the mock forensic examination. However as stated above, isolates 4 and 5 are clearly 
related, both are B. cereus, sharing a large portion of their RAPD profile (Figure 23). 
Figure 23. Electropherogram of similar profiles from two different isolates. 
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A mock forensic test was performed by another student in the Forensic Science 
Department, which in turn allowed for a practical application of the RAPD method. The 
exercise demonstrated RAPD analysis to be useful, but results produced with DNA from 
the same bacterial isolates sometimes produced RAPD profiles that varied somewhat. 
Since the procedure is sensitive to temperature and the concentration of template and 
primer, small variations in these PCR reaction conditions could have significant impact 
on the RAPD profiles generated. Variation in RAPD profiles included products that were 
missing in some runs that had been produced normally in other runs (Figure 24). 
Figure 24. Electropherogram showing variability between different runs of the same isolate of B. cereus.
Whimpy’s profile was slightly different between these two runs. In the first electropherogram (shown in 
blue) products were produced in between 180 and 200bp and above 680bp that were not equally present in 
the second electropherogram (shown in red).
One possible explanation for this phenomenon is aplicon dropout. Aplicon dropout 
occurs when there is too little DNA template, primer binding is disrupted, or the product 
fails to amplify (Butler, 2001).  Thus, in order to be sure a RAPD profile truly is 
representative, repeat runs could be performed on the DNA of an isolate, perhaps varying 
the amount of genomic DNA template added to the PCR reaction. 
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Among the variables responsible for inconsistency in RAPD profiles seen in our study, 
we feel variation in input template DNA amounts is the most likely cause. The quantity 
of DNA recovered from each bacterial culture was estimated using a yield gel that was a 
crude method to estimate the quantity present in each sample. If DNA quantitation were 
performed using a more accurate methodology, perhaps reproducibility would be 
enhanced. 
The reproducibility of the procedure is one of the most important aspects in developing of 
effective RAPD procedure. Annealing temperature is one critical feature of a PCR 
cycling scheme and thus was tested to determine which temperature would give the most 
reproducible results. Different concentrations of template DNA were also tested to 
determine the smallest amount of DNA that would direct reproducible amplification. 
20ng of input DNA template and an annealing temperature of 40oC were found to 
represent PCR cycling conditions that resulted in acceptable reproducibility for the 
RAPD methodology.  Future testing with different primers might reveal a more reliable 
and reproducible combination of temperature and DNA concentration.
A mock forensic experiment demonstrated that spores added to a hot liquid (i.e. coffee) 
or sprayed on inanimate objects, can be used to produce RAPD profiles that are suitable 
for comparison to profiles developed from the parent B. cereus strains originally isolated 
from the soil (Miller, 2005). Therefore, the chromosomal DNA and corresponding RAPD 
profiles do not change significantly when  the recovered spores are germinated in liquid 
53
culture and subjected to RAPD analysis. Thus, in a suspected bioterrorism attack 
involving Bacillus, spores recovered from multiple sites could be analyzed using the 
RAPD procedure to determine if they have a common source. This procedure would be a 
useful addition to the technologies currently in place in forensic labs. 
After the United States became a victim of bioterrorism, many researchers determined 
that ways were needed to quickly investigate and identify bioterrorism agents. 
Vaillancourt et. al. (2001) developed a Multiplex PCR assay using SmartCycler® 
technology for three DNA targets in the plasmids and chromosome of B. anthracis.  
SmartCycler® Technology is a real-time thermal cycler that has up to 96 independently 
programmable reaction sites allowing multiple experiments with different protocols to be 
simultaneously run. The systems software monitors each reaction site during the run as 
the fluorescent signals develop and produces a growth curve as amplification occurs 
(SmartCycler® Technology). The claims of the researchers are that this procedure is 
effective for identification of the strains of B. anthracis, it is sensitive, and only takes 
about one hour. Bergeron et. al. (2003) also used the SmartCycler® to pinpoint single 
nucleotide polymorphisms (SNPs) found on plasmids pX01 and pX02 to quickly identify 
B. anthracis. One of the advantages of this analysis over the traditional culture methods is 
it is rapid, sensitive, and is subjected to computer analysis as compared to human 
analysis. This specific PCR assay is applicable for various clinical specimens, suitable for 
spore detection, and is specific to only B. anthracis (Bergeron et. al., 2003). 
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Another group found that they could identify Bacillus species and could differentiate 
between strains using automated repetitive sequencing based PCR, or rep-PCR, to find 
DNA fingerprints (Webb et. al., 2003). This method utilizes the Caliper 1000 Analyzer 
(Caliper Technologies, Corp, CA) and DiversLab software to analyze non-coding, 
interspersed repeat sequences. The analyzer and software allow for a report to be 
automatically generated that includes gel-like images of the fingerprint to be analyzed to 
determine which species of Bacillus, if any, is present (Webb et. al., 2003). 
One of the advantages of the RAPD procedure developed over the procedures previously 
mentioned is that this method utilizes technology and instruments that are used everyday 
in most forensic labs. Thus, existing instrumentation and techniques allow the procedure 
to be used in any lab that utilizes capillary electrophoresis with no need for new, 
expensive equipment or training. 
4.1 Future Testing 
Results of our study raise some questions suitable for future study: 
• Does the RAPD procedure work with DNA from other bacterial species  or other 
potential biological weapons (i.e. Smallpox virus or Clostridium botulinum
bacterium)?
• Does this procedure work with samples obtained from infected humans or 
animals?
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• Can a process be developed that will allow a RAPD profile to be used as a 
screening test to determine what bioterrorist agent was used in an attack?
• Does the RAPD profile degrade based on factors that are known to cause DNA 
degradation (age of sample, heat, chemicals)?
There are issues that arose during the course of this study that would need to be 
considered before this procedure can be routinely used in a laboratory. One issue is the 
RFU threshold set for designating PCR products. The threshold is the minimum amount 
of RFUs required for a PCR product to be incorporated into the GeneScan software 
analysis. When deterring how to analyze the results, different threshold values were 
evaluated to determine the RFU threshold that gave the most reproducible profiles. 150 
RFUs was chosen as the threshold that produced an acceptable level of reproducibility.  
More experimentation, especially with additional primers sequences might further 
enhance reliability and the usefulness of the RAPD procedure. 
Future enhancements to this study include expanding the list of forensically important 
agents tested. For example, RAPD analysis could possibly be used to reveal 
polymorphisms in the DNA of naturally occurring drugs like marijuana. If a RAPD 
profile database can be constructed, it could be possible to link marijuana confiscated 
from one source to others, or linking it back to an original plant. Such information would 
be valuable in tracing the distribution network of drugs to their source. RAPD analysis 
could also be used by public health officials to investigate outbreaks of food borne illness 
from contaminated food sold to restaurants or grocery stores. Such outbreaks are 
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typically the result of bacterial contamination and represent a scenario very similar to 
applications of RAPD with bioterrorist attacks. 
The ABI 310 Genetic Analyzer has been proven to be extremely useful in forensic testing 
and most forensic labs use the 310 routinely for DNA analysis. This RAPD procedure 
described here is compatible with the 310 DNA analysis platform and thus forensic labs 
will be able to incorporate the RAPD procedure without the need for additional spaces, 
money, and training for new equipment.
The RAPD procedure developed in our study provides a way to match bacterial isolates
recovered from different sources to one another, which will be important in any future 
bioterrorist attacks. A future bioterrorist attack is inevitable whether it be small scale, as 
in the 2001 mailing, or a large aerosol attack of a major population center. It is believed 
that an attack will occur at some future time because bioterrorist agents have been used as 
weapons for hundreds of years. The fact that many countries are suspected of having 
active bioterrorism programs and stockpiles of infectious agents underscores the potential 
for an attack and tools that incorporate modern molecular methods, like RAPD, will 
hopefully better prepare this country and others to respond and effectively investigate 
such attacks and, ultimately help ensure our long term  security. 
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5. Conclusion
In summery the works of this study provided evidence that under carefully controlled 
conditions the RAPD procedure coupled with capillary electrophoresis can be useful in 
linking isolates of B. cereus to each other and to an origin. Thus, it could be possible to 
use this procedure to link outbreaks of B. anthracis to each other. In developing this 
procedure a species of bacteria whose genome was known was used as an example. The 
nature of this procedure allows for investigations to occur without any past knowledge 
about the genome of the organism. Thus, it could be useful if there is ever any future 
attack with an organism (i.e. Hantavirus) whose genetic information is not known, to link 
them to each other and back to an origin without having any knowledge about the genetic 
sequence.
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